GICUX
Price
$18.61
Change
+$0.11 (+0.59%)
Updated
Sep 11 closing price
Net Assets
7.37B
RMBTX
Price
$14.02
Change
+$0.12 (+0.86%)
Updated
Sep 11 closing price
Net Assets
363.92M
Interact to see
Advertisement

GICUX vs RMBTX

GICUX vs RMBTX Comparison Chart in %
View a ticker or compare two or three
VS
GICUX vs. RMBTX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GICUX is a Buy and RMBTX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GICUX has more cash in the bank: 7.37B vs. RMBTX (364M). GICUX pays higher dividends than RMBTX: GICUX (2.66) vs RMBTX (1.44). GICUX was incepted earlier than RMBTX: GICUX (11 years) vs RMBTX (9 years). RMBTX (0.98) is less costly to investors than GICUX (0.88). GICUX is a more actively managed with annual turnover of: 165.00 vs. RMBTX (31.00). RMBTX has a lower initial minimum investment than GICUX: RMBTX (100000) vs GICUX (5000000). RMBTX annual gain was more profitable for investors over the last year : 20.68 vs. GICUX (14.71). GICUX return over 5 years is better than : 46.25 vs. RMBTX (36.50).
GICUXRMBTXGICUX / RMBTX
Total Expense Ratio0.840.9886%
Annual Report Gross Expense Ratio0.880.9890%
Fund Existence11 years9 years-
Gain YTD13.98614.12299%
Front LoadN/AN/A-
Min. Initial Investment50000001000005,000%
Min. Initial Investment IRAN/AN/A-
Net Assets7.37B364M2,024%
Annual Yield % from dividends2.661.44185%
Returns for 1 year14.7120.6871%
Returns for 3 years77.3359.11131%
Returns for 5 years46.2536.50127%
Returns for 10 years126.70N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OAYBX41.170.27
+0.66%
Oakmark Equity and Income Advisor
PGIOX40.12N/A
N/A
Putnam Focused Equity R
RYVLX827.98N/A
N/A
Rydex NASDAQ-100® 2x Strategy A
ISCTX20.54N/A
N/A
Voya SmallCap Opportunities Port S2
EEMEX12.73N/A
N/A
MFS Emerging Markets Equity Research R2